Deciphering ShcA-mediated ROS Production as a Novel Intervention Strategy in Diabetes Therapy
Deciphering ShcA-mediated ROS Production as a Novel Intervention Strategy in Diabetes Therapy
批准号:
9753262
负责人:
FRANKLIN Alan HAYS
金额:
$28.25万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-15 至 2021-07-31
关键词:
Adaptor Signaling ProteinApoptosisApoptoticBindingBiophysicsCardiovascular systemCaspaseCell Culture TechniquesCell SurvivalCell physiologyCellsCellular Stress ResponseClinical TreatmentCollagenCoupledCutaneousCytochrome c PeroxidaseDataDeuteriumDevelopmentDiabetes MellitusDiabetes preventionDiseaseDisulfidesElectron TransportEnergy MetabolismExpression ProfilingFamilyFamily memberFibroblastsFoundationsFutureHumanHydrogenHypertensionInterventionLipidsLocationMammalian CellMass Spectrum AnalysisMediatingMetabolicMetal Ion BindingMitochondriaMolecularMolecular ConformationMolecular StructureMyocardial IschemiaN-terminalOxidation-ReductionOxidative StressOxidoreductaseOxygenPTB DomainPathway interactionsPeripheralPeroxidasesPlayPost-Translational Protein ProcessingProductionProtein CProtein FamilyProtein IsoformsProtein Tyrosine KinaseProteinsReactive Oxygen SpeciesReperfusion InjuryRoleSeveritiesSignal TransductionSourceStrokeStructureSulfhydryl CompoundsSuperoxidesSystemTherapeuticWound HealingX-Ray Crystallographybasebiophysical techniquescytochrome cdesigndiabetes mellitus therapydisulfide bondendothelial dysfunctionhuman diseasein vivoinhibitor/antagonistinsightmouse ShcA proteinnovelp66(ShcA) proteinprotein functionreceptorresponsesmall moleculetherapeutic targettissue culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Oxidative stress is a key determinant in the development of diabetes related microvascular and cardiovascular
complications. ShcA (Src homology and collagen homology) family proteins are prototypical signaling
adaptors that regulate a diverse array of cellular response pathways (e.g., tyrosine kinase (TK) signaling). One
ShcA family member, p66Shc, is also a major source (~30%) of reactive oxygen species (ROS) production in
mammalian cells. ShcA-mediated ROS production is a determinant of stroke size in cardiac ischemia
reperfusion injury and endothelial dysfunction in diabetes (e.g., delayed cutaneous wound healing) and
hypertension. The molecular basis for ShcA enzymatic function is poorly defined or unknown. This project is
focused on defining how ShcA proteins function at the molecular level using a range of biophysical methods.
ShcA proteins have proven difficult to study in defined systems due to their low expression profile in standard
lab systems, they are conformationally variable and prone to posttranslational modification, and they interact
with a broad range of proteins in vivo. The overarching hypothesis of this project is that ShcA proteins function
as molecular rheostats to modulate redox state, cyt c activity, and metabolic flux in a location, conformation,
and binding-dependent manner. We will investigate this hypothesis by pursuing the following Specific Aims: 1)
define the enzymatic mechanism of ShcA-mediated ROS production, 2) define the functional interactions
between ShcA proteins and cytochrome c, and 3) determine the structural basis for ShcA-mediated function.
Outflow from this project will provide a molecular basis for ShcA function as a means to facilitate downstream
development of isoform specific inhibitors of ShcA-mediated ROS production. In addition, ShcA proteins
function at the crossroads of cell survival and apoptosis so this project will further define the role that ShcA
proteins play in determining cellular stress response.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
High-Throughput Protein Production of Membrane Proteins in Saccharomyces cerevisiae.
酿酒酵母膜蛋白的高通量蛋白质生产。
DOI:
10.1007/978-1-4939-9624-7_11
发表时间:
2019
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Johnson,JenniferM, Hays,FranklinA]
通讯作者:
Hays,FranklinA
Deciphering ShcA-mediated ROS Production as a Novel Intervention Strategy in Diabetes Therapy
-
批准号:9349551
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2016
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
Deciphering ShcA-mediated ROS Production as a Novel Intervention Strategy in Diabetes Therapy
-
批准号:9193886
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2016
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
Molecular Basis for Aquaporin Conductance
-
批准号:7153307
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2006
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
Molecular Basis for Aquaporin Conductance
-
批准号:7477234
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2006
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
Molecular Basis for Aquaporin Conductance
-
批准号:7261404
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2006
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
MOLECULAR DETERMINANTS OF GEMCITABINE (Franklin Hays)
-
批准号:9099947
-
项目类别:
-
资助金额:$20.64万
-
财政年份:--
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
Project 4
-
批准号:8521832
-
项目类别:
-
资助金额:$22.2万
-
财政年份:--
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
Project 4
-
批准号:8542667
-
项目类别:
-
资助金额:$20.83万
-
财政年份:--
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
MOLECULAR DETERMINANTS OF GEMCITABINE (Franklin Hays)
-
批准号:8539821
-
项目类别:
-
资助金额:$20.7万
-
财政年份:--
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
Project 4
-
批准号:8692938
-
项目类别:
-
资助金额:$21.08万
-
财政年份:--
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
MOLECULAR DETERMINANTS OF GEMCITABINE (Franklin Hays)
-
批准号:8461445
-
项目类别:
-
资助金额:$22.19万
-
财政年份:--
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
MOLECULAR DETERMINANTS OF GEMCITABINE (Franklin Hays)
-
批准号:8723255
-
项目类别:
-
资助金额:$21.2万
-
财政年份:--
-
负责人:FRANKLIN Alan HAYS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: